LLY · Eli Lilly and Company
21325.00
MXNUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
MXN$19.99T
PE
43.80
EV/EBITDA
29.6
DIV Yield
0.6%
Payout Ratio
26%
MQV Rating
5Very Weak
As at 24/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
Key Fundamentals
EPS 3 yr Growth
216.90%
EBITDA Margin
48.60%
Operating Cashflow
$322,816m
Free Cash Flow Return
30.40%
ROIC
37.40%
Interest Coverage
N/A
Quick Ratio
1.20
Performance
52 weeks range
Low 12975 - 21925.29
Trade Value (12mth)
US$217,629.00
1 week
2.42%
1 month
4.67%
YTD
10.61%
1 year
52.21%
All time high
21925.30
Additional Data
Shares Outstanding (Fully Diluted)
894m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
14-Aug-26
Next Dividend Pay Date
10-Sep-26
Reporting Currency
MXN
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Lilly Endowment, Inc. | Non-Profit Organization |
| David A. Ricks | Individual |
| Employees Provident Fund | Pension Fund |
| OrbiMed Advisors Private Equity | Subsidiary |
| Daniel M. Skovronsky | Individual |
